Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API

Shakhnoza Niyozova

7 ta ish

Tashkent Medical Academy, Tashkent, Uzbekistan

  1. P15.06 * QUALITY OF PATIENTS LIFE WITH METASTATIC TUMORS OF THE SPINE AND SPINAL CORD

    S. G. Gazieva, N. Tolibova, Shakhnoza Niyozova +1

    MaqolaManagement of metastatic bone diseaseNeuro-Oncology20140 iqtibos
    ABI

  2. STUDY OF THE POSSIBILITIES OF PREOPERATIVE CHEMOTHERAPY IN MULTIPLE METASTASIS OF COLORECTAL CANCER IN THE LIVER

    Kh.D. Islamov, Shakhnoza Niyozova

    MaqolaHepatocellular Carcinoma Treatment and PrognosisEurasianUnionofScientists20200 iqtibos
    ABI

  3. Study of the effectiveness of chemotherapy in patients with colorectal cancer depending on the location of the metastatic lesion.

    Sergey Viktorovich Kamishov, Shakhnoza Niyozova

    MaqolaColorectal Cancer Treatments and StudiesJournal of Clinical Oncology20220 iqtibos
    ABI

  4. Effectiveness and safety of combined therapy with pemetrexed and bevacizumab in recurrent and metastatic cervical cancer.

    Shakhnoza Niyozova, Kamila Izrailbekova, Sergey Kamishov +3

    MaqolaEndometrial and Cervical Cancer TreatmentsJournal of Clinical Oncology20250 iqtibos
    ABI

  5. Results of combined therapy with pemetrexed and carboplatin in progressive ovarian cancer.

    Kamila Izrailbekova, Shakhnoza Niyozova, Sergey Kamishov +3

    MaqolaOvarian cancer diagnosis and treatmentJournal of Clinical Oncology20250 iqtibos
    ABI

  6. EFFICACY OF EVEROLIMUS IN COMBINATION WITH LETROZOLE, MEGESTROL ACETATE, AND PACLITAXEL FOR RECURRENT ENDOMETRIAL CANCER

    Kamishov Sergey Viktorovich, Shakhnoza Niyozova, Kamila Izrailbekova +2

    MaqolaEndometrial and Cervical Cancer TreatmentsMedical science of Uzbekistan20250 iqtibos
    ABI

  7. Immunotherapy for advanced gastric cancer: Experience from Uzbekistan.

    Kamila Izrailbekova, Sergey Kamishov, Askar Adilkhodjaev +3

    MaqolaGastric Cancer Management and OutcomesJournal of Clinical Oncology20260 iqtibos
    ABI